Tech Company Financing Transactions
Microbia PE Funding Round
On 3/1/2007, Microbia PE raised $50 million in financing from Ridgeback Capital, Morgan Stanley Expansion Capital and Paperboy Ventures.
Transaction Overview
Company Name
Announced On
3/1/2007
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This capital will be utilized to
support three ongoing Phase 2 studies of Microbia's most advanced
investigational compounds-linaclotide for the treatment of functional
gastrointestinal disorders and MD-0727 for the treatment of
hypercholesterolemia-as well as a growing pipeline of additional drug
candidates.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
60 Westview Street
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Microbia is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marcus Smith
Chief Scientific Officer
Kevin Madden
Browse more venture capital transactions:
Prev: 2/28/2007: Vantage Media venture capital transaction
Next: 3/1/2007: Visiogen venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs